Global Influenza Diagnostics Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Influenza Diagnostics market size was valued at US$ 2713 million in 2024 and is forecast to a readjusted size of USD 4102 million by 2031 with a CAGR of 6.2% during review period.
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.
This report is a detailed and comprehensive analysis for global Influenza Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Influenza Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Influenza Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Influenza Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Influenza Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Influenza Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Influenza Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Influenza Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Influenza Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Influenza Diagnostics, with revenue, gross margin, and global market share of Influenza Diagnostics from 2020 to 2025.
Chapter 3, the Influenza Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Influenza Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Influenza Diagnostics.
Chapter 13, to describe Influenza Diagnostics research findings and conclusion.
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.
This report is a detailed and comprehensive analysis for global Influenza Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Influenza Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Influenza Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Influenza Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Influenza Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Influenza Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Influenza Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Influenza Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- RIDT
- RT-PCR
- Cell Culture
- Others
- Hospitals
- POCT
- Others
- BD
- Abbott (Include Alere)
- Roche
- SIEMENS
- Analytik Jena
- Quidel
- Thermo Fisher
- Meridian Bioscience
- BioMerieux
- Sekisui Diagnostics
- Response Biomedical
- SA Scientific
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Influenza Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Influenza Diagnostics, with revenue, gross margin, and global market share of Influenza Diagnostics from 2020 to 2025.
Chapter 3, the Influenza Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Influenza Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Influenza Diagnostics.
Chapter 13, to describe Influenza Diagnostics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Influenza Diagnostics by Type
1.3.1 Overview: Global Influenza Diagnostics Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Influenza Diagnostics Consumption Value Market Share by Type in 2024
1.3.3 RIDT
1.3.4 RT-PCR
1.3.5 Cell Culture
1.3.6 Others
1.4 Global Influenza Diagnostics Market by Application
1.4.1 Overview: Global Influenza Diagnostics Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 POCT
1.4.4 Others
1.5 Global Influenza Diagnostics Market Size & Forecast
1.6 Global Influenza Diagnostics Market Size and Forecast by Region
1.6.1 Global Influenza Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Influenza Diagnostics Market Size by Region, (2020-2031)
1.6.3 North America Influenza Diagnostics Market Size and Prospect (2020-2031)
1.6.4 Europe Influenza Diagnostics Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Influenza Diagnostics Market Size and Prospect (2020-2031)
1.6.6 South America Influenza Diagnostics Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Influenza Diagnostics Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Influenza Diagnostics Product and Solutions
2.1.4 BD Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 BD Recent Developments and Future Plans
2.2 Abbott (Include Alere)
2.2.1 Abbott (Include Alere) Details
2.2.2 Abbott (Include Alere) Major Business
2.2.3 Abbott (Include Alere) Influenza Diagnostics Product and Solutions
2.2.4 Abbott (Include Alere) Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Abbott (Include Alere) Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Influenza Diagnostics Product and Solutions
2.3.4 Roche Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Roche Recent Developments and Future Plans
2.4 SIEMENS
2.4.1 SIEMENS Details
2.4.2 SIEMENS Major Business
2.4.3 SIEMENS Influenza Diagnostics Product and Solutions
2.4.4 SIEMENS Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 SIEMENS Recent Developments and Future Plans
2.5 Analytik Jena
2.5.1 Analytik Jena Details
2.5.2 Analytik Jena Major Business
2.5.3 Analytik Jena Influenza Diagnostics Product and Solutions
2.5.4 Analytik Jena Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Analytik Jena Recent Developments and Future Plans
2.6 Quidel
2.6.1 Quidel Details
2.6.2 Quidel Major Business
2.6.3 Quidel Influenza Diagnostics Product and Solutions
2.6.4 Quidel Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Quidel Recent Developments and Future Plans
2.7 Thermo Fisher
2.7.1 Thermo Fisher Details
2.7.2 Thermo Fisher Major Business
2.7.3 Thermo Fisher Influenza Diagnostics Product and Solutions
2.7.4 Thermo Fisher Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Thermo Fisher Recent Developments and Future Plans
2.8 Meridian Bioscience
2.8.1 Meridian Bioscience Details
2.8.2 Meridian Bioscience Major Business
2.8.3 Meridian Bioscience Influenza Diagnostics Product and Solutions
2.8.4 Meridian Bioscience Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Meridian Bioscience Recent Developments and Future Plans
2.9 BioMerieux
2.9.1 BioMerieux Details
2.9.2 BioMerieux Major Business
2.9.3 BioMerieux Influenza Diagnostics Product and Solutions
2.9.4 BioMerieux Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 BioMerieux Recent Developments and Future Plans
2.10 Sekisui Diagnostics
2.10.1 Sekisui Diagnostics Details
2.10.2 Sekisui Diagnostics Major Business
2.10.3 Sekisui Diagnostics Influenza Diagnostics Product and Solutions
2.10.4 Sekisui Diagnostics Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Sekisui Diagnostics Recent Developments and Future Plans
2.11 Response Biomedical
2.11.1 Response Biomedical Details
2.11.2 Response Biomedical Major Business
2.11.3 Response Biomedical Influenza Diagnostics Product and Solutions
2.11.4 Response Biomedical Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Response Biomedical Recent Developments and Future Plans
2.12 SA Scientific
2.12.1 SA Scientific Details
2.12.2 SA Scientific Major Business
2.12.3 SA Scientific Influenza Diagnostics Product and Solutions
2.12.4 SA Scientific Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 SA Scientific Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Influenza Diagnostics Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Influenza Diagnostics by Company Revenue
3.2.2 Top 3 Influenza Diagnostics Players Market Share in 2024
3.2.3 Top 6 Influenza Diagnostics Players Market Share in 2024
3.3 Influenza Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Influenza Diagnostics Market: Region Footprint
3.3.2 Influenza Diagnostics Market: Company Product Type Footprint
3.3.3 Influenza Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Influenza Diagnostics Consumption Value and Market Share by Type (2020-2025)
4.2 Global Influenza Diagnostics Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Influenza Diagnostics Consumption Value Market Share by Application (2020-2025)
5.2 Global Influenza Diagnostics Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Influenza Diagnostics Consumption Value by Type (2020-2031)
6.2 North America Influenza Diagnostics Market Size by Application (2020-2031)
6.3 North America Influenza Diagnostics Market Size by Country
6.3.1 North America Influenza Diagnostics Consumption Value by Country (2020-2031)
6.3.2 United States Influenza Diagnostics Market Size and Forecast (2020-2031)
6.3.3 Canada Influenza Diagnostics Market Size and Forecast (2020-2031)
6.3.4 Mexico Influenza Diagnostics Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Influenza Diagnostics Consumption Value by Type (2020-2031)
7.2 Europe Influenza Diagnostics Consumption Value by Application (2020-2031)
7.3 Europe Influenza Diagnostics Market Size by Country
7.3.1 Europe Influenza Diagnostics Consumption Value by Country (2020-2031)
7.3.2 Germany Influenza Diagnostics Market Size and Forecast (2020-2031)
7.3.3 France Influenza Diagnostics Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Influenza Diagnostics Market Size and Forecast (2020-2031)
7.3.5 Russia Influenza Diagnostics Market Size and Forecast (2020-2031)
7.3.6 Italy Influenza Diagnostics Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Influenza Diagnostics Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Influenza Diagnostics Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Influenza Diagnostics Market Size by Region
8.3.1 Asia-Pacific Influenza Diagnostics Consumption Value by Region (2020-2031)
8.3.2 China Influenza Diagnostics Market Size and Forecast (2020-2031)
8.3.3 Japan Influenza Diagnostics Market Size and Forecast (2020-2031)
8.3.4 South Korea Influenza Diagnostics Market Size and Forecast (2020-2031)
8.3.5 India Influenza Diagnostics Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Influenza Diagnostics Market Size and Forecast (2020-2031)
8.3.7 Australia Influenza Diagnostics Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Influenza Diagnostics Consumption Value by Type (2020-2031)
9.2 South America Influenza Diagnostics Consumption Value by Application (2020-2031)
9.3 South America Influenza Diagnostics Market Size by Country
9.3.1 South America Influenza Diagnostics Consumption Value by Country (2020-2031)
9.3.2 Brazil Influenza Diagnostics Market Size and Forecast (2020-2031)
9.3.3 Argentina Influenza Diagnostics Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Influenza Diagnostics Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Influenza Diagnostics Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Influenza Diagnostics Market Size by Country
10.3.1 Middle East & Africa Influenza Diagnostics Consumption Value by Country (2020-2031)
10.3.2 Turkey Influenza Diagnostics Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Influenza Diagnostics Market Size and Forecast (2020-2031)
10.3.4 UAE Influenza Diagnostics Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Influenza Diagnostics Market Drivers
11.2 Influenza Diagnostics Market Restraints
11.3 Influenza Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Influenza Diagnostics Industry Chain
12.2 Influenza Diagnostics Upstream Analysis
12.3 Influenza Diagnostics Midstream Analysis
12.4 Influenza Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Influenza Diagnostics by Type
1.3.1 Overview: Global Influenza Diagnostics Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Influenza Diagnostics Consumption Value Market Share by Type in 2024
1.3.3 RIDT
1.3.4 RT-PCR
1.3.5 Cell Culture
1.3.6 Others
1.4 Global Influenza Diagnostics Market by Application
1.4.1 Overview: Global Influenza Diagnostics Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 POCT
1.4.4 Others
1.5 Global Influenza Diagnostics Market Size & Forecast
1.6 Global Influenza Diagnostics Market Size and Forecast by Region
1.6.1 Global Influenza Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Influenza Diagnostics Market Size by Region, (2020-2031)
1.6.3 North America Influenza Diagnostics Market Size and Prospect (2020-2031)
1.6.4 Europe Influenza Diagnostics Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Influenza Diagnostics Market Size and Prospect (2020-2031)
1.6.6 South America Influenza Diagnostics Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Influenza Diagnostics Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Influenza Diagnostics Product and Solutions
2.1.4 BD Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 BD Recent Developments and Future Plans
2.2 Abbott (Include Alere)
2.2.1 Abbott (Include Alere) Details
2.2.2 Abbott (Include Alere) Major Business
2.2.3 Abbott (Include Alere) Influenza Diagnostics Product and Solutions
2.2.4 Abbott (Include Alere) Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Abbott (Include Alere) Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Influenza Diagnostics Product and Solutions
2.3.4 Roche Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Roche Recent Developments and Future Plans
2.4 SIEMENS
2.4.1 SIEMENS Details
2.4.2 SIEMENS Major Business
2.4.3 SIEMENS Influenza Diagnostics Product and Solutions
2.4.4 SIEMENS Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 SIEMENS Recent Developments and Future Plans
2.5 Analytik Jena
2.5.1 Analytik Jena Details
2.5.2 Analytik Jena Major Business
2.5.3 Analytik Jena Influenza Diagnostics Product and Solutions
2.5.4 Analytik Jena Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Analytik Jena Recent Developments and Future Plans
2.6 Quidel
2.6.1 Quidel Details
2.6.2 Quidel Major Business
2.6.3 Quidel Influenza Diagnostics Product and Solutions
2.6.4 Quidel Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Quidel Recent Developments and Future Plans
2.7 Thermo Fisher
2.7.1 Thermo Fisher Details
2.7.2 Thermo Fisher Major Business
2.7.3 Thermo Fisher Influenza Diagnostics Product and Solutions
2.7.4 Thermo Fisher Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Thermo Fisher Recent Developments and Future Plans
2.8 Meridian Bioscience
2.8.1 Meridian Bioscience Details
2.8.2 Meridian Bioscience Major Business
2.8.3 Meridian Bioscience Influenza Diagnostics Product and Solutions
2.8.4 Meridian Bioscience Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Meridian Bioscience Recent Developments and Future Plans
2.9 BioMerieux
2.9.1 BioMerieux Details
2.9.2 BioMerieux Major Business
2.9.3 BioMerieux Influenza Diagnostics Product and Solutions
2.9.4 BioMerieux Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 BioMerieux Recent Developments and Future Plans
2.10 Sekisui Diagnostics
2.10.1 Sekisui Diagnostics Details
2.10.2 Sekisui Diagnostics Major Business
2.10.3 Sekisui Diagnostics Influenza Diagnostics Product and Solutions
2.10.4 Sekisui Diagnostics Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Sekisui Diagnostics Recent Developments and Future Plans
2.11 Response Biomedical
2.11.1 Response Biomedical Details
2.11.2 Response Biomedical Major Business
2.11.3 Response Biomedical Influenza Diagnostics Product and Solutions
2.11.4 Response Biomedical Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Response Biomedical Recent Developments and Future Plans
2.12 SA Scientific
2.12.1 SA Scientific Details
2.12.2 SA Scientific Major Business
2.12.3 SA Scientific Influenza Diagnostics Product and Solutions
2.12.4 SA Scientific Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 SA Scientific Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Influenza Diagnostics Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Influenza Diagnostics by Company Revenue
3.2.2 Top 3 Influenza Diagnostics Players Market Share in 2024
3.2.3 Top 6 Influenza Diagnostics Players Market Share in 2024
3.3 Influenza Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Influenza Diagnostics Market: Region Footprint
3.3.2 Influenza Diagnostics Market: Company Product Type Footprint
3.3.3 Influenza Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Influenza Diagnostics Consumption Value and Market Share by Type (2020-2025)
4.2 Global Influenza Diagnostics Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Influenza Diagnostics Consumption Value Market Share by Application (2020-2025)
5.2 Global Influenza Diagnostics Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Influenza Diagnostics Consumption Value by Type (2020-2031)
6.2 North America Influenza Diagnostics Market Size by Application (2020-2031)
6.3 North America Influenza Diagnostics Market Size by Country
6.3.1 North America Influenza Diagnostics Consumption Value by Country (2020-2031)
6.3.2 United States Influenza Diagnostics Market Size and Forecast (2020-2031)
6.3.3 Canada Influenza Diagnostics Market Size and Forecast (2020-2031)
6.3.4 Mexico Influenza Diagnostics Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Influenza Diagnostics Consumption Value by Type (2020-2031)
7.2 Europe Influenza Diagnostics Consumption Value by Application (2020-2031)
7.3 Europe Influenza Diagnostics Market Size by Country
7.3.1 Europe Influenza Diagnostics Consumption Value by Country (2020-2031)
7.3.2 Germany Influenza Diagnostics Market Size and Forecast (2020-2031)
7.3.3 France Influenza Diagnostics Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Influenza Diagnostics Market Size and Forecast (2020-2031)
7.3.5 Russia Influenza Diagnostics Market Size and Forecast (2020-2031)
7.3.6 Italy Influenza Diagnostics Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Influenza Diagnostics Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Influenza Diagnostics Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Influenza Diagnostics Market Size by Region
8.3.1 Asia-Pacific Influenza Diagnostics Consumption Value by Region (2020-2031)
8.3.2 China Influenza Diagnostics Market Size and Forecast (2020-2031)
8.3.3 Japan Influenza Diagnostics Market Size and Forecast (2020-2031)
8.3.4 South Korea Influenza Diagnostics Market Size and Forecast (2020-2031)
8.3.5 India Influenza Diagnostics Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Influenza Diagnostics Market Size and Forecast (2020-2031)
8.3.7 Australia Influenza Diagnostics Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Influenza Diagnostics Consumption Value by Type (2020-2031)
9.2 South America Influenza Diagnostics Consumption Value by Application (2020-2031)
9.3 South America Influenza Diagnostics Market Size by Country
9.3.1 South America Influenza Diagnostics Consumption Value by Country (2020-2031)
9.3.2 Brazil Influenza Diagnostics Market Size and Forecast (2020-2031)
9.3.3 Argentina Influenza Diagnostics Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Influenza Diagnostics Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Influenza Diagnostics Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Influenza Diagnostics Market Size by Country
10.3.1 Middle East & Africa Influenza Diagnostics Consumption Value by Country (2020-2031)
10.3.2 Turkey Influenza Diagnostics Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Influenza Diagnostics Market Size and Forecast (2020-2031)
10.3.4 UAE Influenza Diagnostics Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Influenza Diagnostics Market Drivers
11.2 Influenza Diagnostics Market Restraints
11.3 Influenza Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Influenza Diagnostics Industry Chain
12.2 Influenza Diagnostics Upstream Analysis
12.3 Influenza Diagnostics Midstream Analysis
12.4 Influenza Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Influenza Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Influenza Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Influenza Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Influenza Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 5. BD Company Information, Head Office, and Major Competitors
Table 6. BD Major Business
Table 7. BD Influenza Diagnostics Product and Solutions
Table 8. BD Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. BD Recent Developments and Future Plans
Table 10. Abbott (Include Alere) Company Information, Head Office, and Major Competitors
Table 11. Abbott (Include Alere) Major Business
Table 12. Abbott (Include Alere) Influenza Diagnostics Product and Solutions
Table 13. Abbott (Include Alere) Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Abbott (Include Alere) Recent Developments and Future Plans
Table 15. Roche Company Information, Head Office, and Major Competitors
Table 16. Roche Major Business
Table 17. Roche Influenza Diagnostics Product and Solutions
Table 18. Roche Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. SIEMENS Company Information, Head Office, and Major Competitors
Table 20. SIEMENS Major Business
Table 21. SIEMENS Influenza Diagnostics Product and Solutions
Table 22. SIEMENS Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. SIEMENS Recent Developments and Future Plans
Table 24. Analytik Jena Company Information, Head Office, and Major Competitors
Table 25. Analytik Jena Major Business
Table 26. Analytik Jena Influenza Diagnostics Product and Solutions
Table 27. Analytik Jena Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Analytik Jena Recent Developments and Future Plans
Table 29. Quidel Company Information, Head Office, and Major Competitors
Table 30. Quidel Major Business
Table 31. Quidel Influenza Diagnostics Product and Solutions
Table 32. Quidel Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Quidel Recent Developments and Future Plans
Table 34. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 35. Thermo Fisher Major Business
Table 36. Thermo Fisher Influenza Diagnostics Product and Solutions
Table 37. Thermo Fisher Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Thermo Fisher Recent Developments and Future Plans
Table 39. Meridian Bioscience Company Information, Head Office, and Major Competitors
Table 40. Meridian Bioscience Major Business
Table 41. Meridian Bioscience Influenza Diagnostics Product and Solutions
Table 42. Meridian Bioscience Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Meridian Bioscience Recent Developments and Future Plans
Table 44. BioMerieux Company Information, Head Office, and Major Competitors
Table 45. BioMerieux Major Business
Table 46. BioMerieux Influenza Diagnostics Product and Solutions
Table 47. BioMerieux Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. BioMerieux Recent Developments and Future Plans
Table 49. Sekisui Diagnostics Company Information, Head Office, and Major Competitors
Table 50. Sekisui Diagnostics Major Business
Table 51. Sekisui Diagnostics Influenza Diagnostics Product and Solutions
Table 52. Sekisui Diagnostics Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Sekisui Diagnostics Recent Developments and Future Plans
Table 54. Response Biomedical Company Information, Head Office, and Major Competitors
Table 55. Response Biomedical Major Business
Table 56. Response Biomedical Influenza Diagnostics Product and Solutions
Table 57. Response Biomedical Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Response Biomedical Recent Developments and Future Plans
Table 59. SA Scientific Company Information, Head Office, and Major Competitors
Table 60. SA Scientific Major Business
Table 61. SA Scientific Influenza Diagnostics Product and Solutions
Table 62. SA Scientific Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. SA Scientific Recent Developments and Future Plans
Table 64. Global Influenza Diagnostics Revenue (USD Million) by Players (2020-2025)
Table 65. Global Influenza Diagnostics Revenue Share by Players (2020-2025)
Table 66. Breakdown of Influenza Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 67. Market Position of Players in Influenza Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 68. Head Office of Key Influenza Diagnostics Players
Table 69. Influenza Diagnostics Market: Company Product Type Footprint
Table 70. Influenza Diagnostics Market: Company Product Application Footprint
Table 71. Influenza Diagnostics New Market Entrants and Barriers to Market Entry
Table 72. Influenza Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 73. Global Influenza Diagnostics Consumption Value (USD Million) by Type (2020-2025)
Table 74. Global Influenza Diagnostics Consumption Value Share by Type (2020-2025)
Table 75. Global Influenza Diagnostics Consumption Value Forecast by Type (2026-2031)
Table 76. Global Influenza Diagnostics Consumption Value by Application (2020-2025)
Table 77. Global Influenza Diagnostics Consumption Value Forecast by Application (2026-2031)
Table 78. North America Influenza Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 79. North America Influenza Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 80. North America Influenza Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 81. North America Influenza Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 82. North America Influenza Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 83. North America Influenza Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 84. Europe Influenza Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 85. Europe Influenza Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 86. Europe Influenza Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 87. Europe Influenza Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 88. Europe Influenza Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 89. Europe Influenza Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 90. Asia-Pacific Influenza Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 91. Asia-Pacific Influenza Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 92. Asia-Pacific Influenza Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 93. Asia-Pacific Influenza Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 94. Asia-Pacific Influenza Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 95. Asia-Pacific Influenza Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 96. South America Influenza Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 97. South America Influenza Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 98. South America Influenza Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 99. South America Influenza Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 100. South America Influenza Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 101. South America Influenza Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 102. Middle East & Africa Influenza Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 103. Middle East & Africa Influenza Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 104. Middle East & Africa Influenza Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 105. Middle East & Africa Influenza Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 106. Middle East & Africa Influenza Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 107. Middle East & Africa Influenza Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 108. Global Key Players of Influenza Diagnostics Upstream (Raw Materials)
Table 109. Global Influenza Diagnostics Typical Customers
Table 1. Global Influenza Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Influenza Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Influenza Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Influenza Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 5. BD Company Information, Head Office, and Major Competitors
Table 6. BD Major Business
Table 7. BD Influenza Diagnostics Product and Solutions
Table 8. BD Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. BD Recent Developments and Future Plans
Table 10. Abbott (Include Alere) Company Information, Head Office, and Major Competitors
Table 11. Abbott (Include Alere) Major Business
Table 12. Abbott (Include Alere) Influenza Diagnostics Product and Solutions
Table 13. Abbott (Include Alere) Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Abbott (Include Alere) Recent Developments and Future Plans
Table 15. Roche Company Information, Head Office, and Major Competitors
Table 16. Roche Major Business
Table 17. Roche Influenza Diagnostics Product and Solutions
Table 18. Roche Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. SIEMENS Company Information, Head Office, and Major Competitors
Table 20. SIEMENS Major Business
Table 21. SIEMENS Influenza Diagnostics Product and Solutions
Table 22. SIEMENS Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. SIEMENS Recent Developments and Future Plans
Table 24. Analytik Jena Company Information, Head Office, and Major Competitors
Table 25. Analytik Jena Major Business
Table 26. Analytik Jena Influenza Diagnostics Product and Solutions
Table 27. Analytik Jena Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Analytik Jena Recent Developments and Future Plans
Table 29. Quidel Company Information, Head Office, and Major Competitors
Table 30. Quidel Major Business
Table 31. Quidel Influenza Diagnostics Product and Solutions
Table 32. Quidel Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Quidel Recent Developments and Future Plans
Table 34. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 35. Thermo Fisher Major Business
Table 36. Thermo Fisher Influenza Diagnostics Product and Solutions
Table 37. Thermo Fisher Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Thermo Fisher Recent Developments and Future Plans
Table 39. Meridian Bioscience Company Information, Head Office, and Major Competitors
Table 40. Meridian Bioscience Major Business
Table 41. Meridian Bioscience Influenza Diagnostics Product and Solutions
Table 42. Meridian Bioscience Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Meridian Bioscience Recent Developments and Future Plans
Table 44. BioMerieux Company Information, Head Office, and Major Competitors
Table 45. BioMerieux Major Business
Table 46. BioMerieux Influenza Diagnostics Product and Solutions
Table 47. BioMerieux Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. BioMerieux Recent Developments and Future Plans
Table 49. Sekisui Diagnostics Company Information, Head Office, and Major Competitors
Table 50. Sekisui Diagnostics Major Business
Table 51. Sekisui Diagnostics Influenza Diagnostics Product and Solutions
Table 52. Sekisui Diagnostics Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Sekisui Diagnostics Recent Developments and Future Plans
Table 54. Response Biomedical Company Information, Head Office, and Major Competitors
Table 55. Response Biomedical Major Business
Table 56. Response Biomedical Influenza Diagnostics Product and Solutions
Table 57. Response Biomedical Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Response Biomedical Recent Developments and Future Plans
Table 59. SA Scientific Company Information, Head Office, and Major Competitors
Table 60. SA Scientific Major Business
Table 61. SA Scientific Influenza Diagnostics Product and Solutions
Table 62. SA Scientific Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. SA Scientific Recent Developments and Future Plans
Table 64. Global Influenza Diagnostics Revenue (USD Million) by Players (2020-2025)
Table 65. Global Influenza Diagnostics Revenue Share by Players (2020-2025)
Table 66. Breakdown of Influenza Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 67. Market Position of Players in Influenza Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 68. Head Office of Key Influenza Diagnostics Players
Table 69. Influenza Diagnostics Market: Company Product Type Footprint
Table 70. Influenza Diagnostics Market: Company Product Application Footprint
Table 71. Influenza Diagnostics New Market Entrants and Barriers to Market Entry
Table 72. Influenza Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 73. Global Influenza Diagnostics Consumption Value (USD Million) by Type (2020-2025)
Table 74. Global Influenza Diagnostics Consumption Value Share by Type (2020-2025)
Table 75. Global Influenza Diagnostics Consumption Value Forecast by Type (2026-2031)
Table 76. Global Influenza Diagnostics Consumption Value by Application (2020-2025)
Table 77. Global Influenza Diagnostics Consumption Value Forecast by Application (2026-2031)
Table 78. North America Influenza Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 79. North America Influenza Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 80. North America Influenza Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 81. North America Influenza Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 82. North America Influenza Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 83. North America Influenza Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 84. Europe Influenza Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 85. Europe Influenza Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 86. Europe Influenza Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 87. Europe Influenza Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 88. Europe Influenza Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 89. Europe Influenza Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 90. Asia-Pacific Influenza Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 91. Asia-Pacific Influenza Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 92. Asia-Pacific Influenza Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 93. Asia-Pacific Influenza Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 94. Asia-Pacific Influenza Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 95. Asia-Pacific Influenza Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 96. South America Influenza Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 97. South America Influenza Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 98. South America Influenza Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 99. South America Influenza Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 100. South America Influenza Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 101. South America Influenza Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 102. Middle East & Africa Influenza Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 103. Middle East & Africa Influenza Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 104. Middle East & Africa Influenza Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 105. Middle East & Africa Influenza Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 106. Middle East & Africa Influenza Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 107. Middle East & Africa Influenza Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 108. Global Key Players of Influenza Diagnostics Upstream (Raw Materials)
Table 109. Global Influenza Diagnostics Typical Customers
LIST OF FIGURES
Figure 1. Influenza Diagnostics Picture
Figure 2. Global Influenza Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Influenza Diagnostics Consumption Value Market Share by Type in 2024
Figure 4. RIDT
Figure 5. RT-PCR
Figure 6. Cell Culture
Figure 7. Others
Figure 8. Global Influenza Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Influenza Diagnostics Consumption Value Market Share by Application in 2024
Figure 10. Hospitals Picture
Figure 11. POCT Picture
Figure 12. Others Picture
Figure 13. Global Influenza Diagnostics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Influenza Diagnostics Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Market Influenza Diagnostics Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Influenza Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Influenza Diagnostics Consumption Value Market Share by Region in 2024
Figure 18. North America Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Influenza Diagnostics Revenue Share by Players in 2024
Figure 25. Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 26. Market Share of Influenza Diagnostics by Player Revenue in 2024
Figure 27. Top 3 Influenza Diagnostics Players Market Share in 2024
Figure 28. Top 6 Influenza Diagnostics Players Market Share in 2024
Figure 29. Global Influenza Diagnostics Consumption Value Share by Type (2020-2025)
Figure 30. Global Influenza Diagnostics Market Share Forecast by Type (2026-2031)
Figure 31. Global Influenza Diagnostics Consumption Value Share by Application (2020-2025)
Figure 32. Global Influenza Diagnostics Market Share Forecast by Application (2026-2031)
Figure 33. North America Influenza Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 34. North America Influenza Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Influenza Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Influenza Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 40. Europe Influenza Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Influenza Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 43. France Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Influenza Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 48. Asia-Pacific Influenza Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Influenza Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 50. China Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 53. India Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Influenza Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 57. South America Influenza Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Influenza Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Influenza Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 62. Middle East & Africa Influenza Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Influenza Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 64. Turkey Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 67. Influenza Diagnostics Market Drivers
Figure 68. Influenza Diagnostics Market Restraints
Figure 69. Influenza Diagnostics Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Influenza Diagnostics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Influenza Diagnostics Picture
Figure 2. Global Influenza Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Influenza Diagnostics Consumption Value Market Share by Type in 2024
Figure 4. RIDT
Figure 5. RT-PCR
Figure 6. Cell Culture
Figure 7. Others
Figure 8. Global Influenza Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Influenza Diagnostics Consumption Value Market Share by Application in 2024
Figure 10. Hospitals Picture
Figure 11. POCT Picture
Figure 12. Others Picture
Figure 13. Global Influenza Diagnostics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Influenza Diagnostics Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Market Influenza Diagnostics Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Influenza Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Influenza Diagnostics Consumption Value Market Share by Region in 2024
Figure 18. North America Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Influenza Diagnostics Revenue Share by Players in 2024
Figure 25. Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 26. Market Share of Influenza Diagnostics by Player Revenue in 2024
Figure 27. Top 3 Influenza Diagnostics Players Market Share in 2024
Figure 28. Top 6 Influenza Diagnostics Players Market Share in 2024
Figure 29. Global Influenza Diagnostics Consumption Value Share by Type (2020-2025)
Figure 30. Global Influenza Diagnostics Market Share Forecast by Type (2026-2031)
Figure 31. Global Influenza Diagnostics Consumption Value Share by Application (2020-2025)
Figure 32. Global Influenza Diagnostics Market Share Forecast by Application (2026-2031)
Figure 33. North America Influenza Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 34. North America Influenza Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Influenza Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Influenza Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 40. Europe Influenza Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Influenza Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 43. France Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Influenza Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 48. Asia-Pacific Influenza Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Influenza Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 50. China Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 53. India Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Influenza Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 57. South America Influenza Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Influenza Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Influenza Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 62. Middle East & Africa Influenza Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Influenza Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 64. Turkey Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Influenza Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 67. Influenza Diagnostics Market Drivers
Figure 68. Influenza Diagnostics Market Restraints
Figure 69. Influenza Diagnostics Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Influenza Diagnostics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
